Cancel

Investors

We’re dsm-firmenich – innovators in nutrition, health, and beauty

dsm-firmenich at a glance
Jump to

dsm-firmenich at a glance

Two global leaders in science and innovation, each with a world-class portfolio, have come together to create dsm-firmenich. Our roots may go back well over a century, but we’re always looking forward.

Read more about dsm-firmenich

Financial calendar

See all

February 12, 2026
Full Year 2025 results

May 6, 2026
Q1 2026 trading update

May 7, 2026
Annual General Meeting 2026

Purpose-driven performance

dsm-firmenich brings together two iconic companies. We have deep roots and a bright future, with shared strengths and unrivaled expertise that drive positive impact in everything we do. Our purpose is to bring progress to life – creating a world of potential for customers, communities, consumers, and investors.
See our latest results

dsm-firmenich reports Full Year 2025 results

dsm-firmenich announced its full year 2025 results on February 12, 2026.

Read more
Share price:

Contact Investor relations

Whether you’re a shareholder, potential shareholder, or analyst, our Investor relations team is on hand to answer your questions.

Get in touch

EMTN Program Documents

Discover and read about our EMTN Program related documents.

Read more
Latest news

  • 12 February 2026

    dsm-firmenich reports full year 2025 results

    Read more

  • 9 February 2026

    dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)

    Read more

  • 9 February 2026

    dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners

    Read more

  • 14 January 2026

    dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer

    Read more

  • 3 December 2025

    dsm-firmenich completes €1.08 billion share repurchase program

    Read more

  • 25 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 18 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 11 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 4 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 30 October 2025

    dsm-firmenich Q3 2025 trading update

    Read more

  • 28 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 21 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 14 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 7 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 30 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 23 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 16 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 9 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 3 September 2025

    dsm-firmenich achieves target of 100% purchased renewable electricity

    Read more

  • 2 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 1 September 2025

    dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company

    Read more

  • 26 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 19 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 12 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 5 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 31 July 2025

    dsm-firmenich reports H1 2025 results

    Read more

  • 29 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 22 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 15 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 8 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 1 July 2025

    dsm-firmenich announces redemption of €750 million hybrid bond

    Read more

  • 1 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 27 June 2025

    dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion

    Read more

  • 24 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 17 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 10 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 3 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 2 June 2025

    dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

    Read more

  • 27 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 20 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 13 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 6 May 2025

    dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025

    Read more

  • 6 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 30 April 2025

    dsm-firmenich Q1 2025 trading update

    Read more

  • 29 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 22 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 15 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 8 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

    Read more

  • 8 April 2025

    Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

    Read more

  • 3 April 2025

    dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

    Read more

  • 1 April 2025

    dsm-firmenich announces share repurchase program to cover share plans and reduce capital

    Read more

  • 25 March 2025

    dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day

    Read more

  • 28 February 2025

    dsm-firmenich publishes 2024 Integrated Annual Report

    Read more

  • 19 February 2025

    dsm-firmenich issues €750 million long-term bond

    Read more

  • 13 February 2025

    dsm-firmenich reports full year 2024 results

    Read more

  • 11 February 2025

    dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

    Read more

  • 21 November 2024

    DSM-Firmenich AG sold all of its stake in Robertet S.A.

    Read more

  • 15 November 2024

    DSM-Firmenich AG sold the majority of its stake in Robertet S.A.

    Read more

  • 14 November 2024

    DSM-Firmenich AG to sell part of its stake in Robertet S.A.

    Read more

  • 31 October 2024

    dsm-firmenich Q3 2024 trading update

    Read more

  • 24 October 2024

    dsm-firmenich receives validation from the Science Based Targets initiative for its 2045 net-zero targets

    Read more

  • 2 October 2024

    dsm-firmenich completes the sale of yeast extract business to Lesaffre

    Read more

  • 1 October 2024

    dsm-firmenich completes the sale of its MEG-3® fish oil business to KD Pharma Group SA

    Read more

  • 8 August 2024

    dsm-firmenich concludes new €1.8 billion Revolving Credit Facility

    Read more

  • 30 July 2024

    dsm-firmenich reports H1 2024 results

    Read more

  • 18 July 2024

    dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group

    Read more

  • 26 June 2024

    dsm-firmenich issues €800 million long-term bond

    Read more

  • 14 June 2024

    DSM shareholders can voluntarily transfer their shares to dsm-firmenich before July 2, 2024, 17:45 hours CEST

    Read more

  • 12 June 2024

    dsm-firmenich announces sale of yeast extract business to Lesaffre

    Read more

  • 3 June 2024

    dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty

    Read more

  • 31 May 2024

    dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform

    Read more

  • 29 May 2024

    Methane-reducing feed ingredient Bovaer® ready for US market launch

    Read more

  • 7 May 2024

    dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024

    Read more

  • 7 May 2024

    Share repurchase program to cover share plans completed

    Read more

  • 2 May 2024

    dsm-firmenich Q1 2024 trading update

    Read more

  • 30 April 2024

    dsm-firmenich's progress on share repurchase program to cover share plans

    Read more

  • 16 April 2024

    dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans

    Read more

  • 8 April 2024

    dsm-firmenich announces repurchase of 1.5m shares to cover share plans

    Read more

  • 8 March 2024

    dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China

    Read more

  • 29 February 2024

    dsm-firmenich publishes 2023 Integrated Annual Report

    Read more

  • 15 February 2024

    dsm-firmenich reports 2023 full year results

    Read more

  • 14 February 2024

    dsm-firmenich to separate out Animal Nutrition & Health business from the Group

    Read more

  • 12 February 2024

    dsm-firmenich completes voluntary cash offer for DSM shares

    Read more

  • 8 January 2024

    dsm-firmenich makes voluntary cash offer for DSM shares

    Read more

  • 31 October 2023

    dsm-firmenich reports Q3 2023 results

    Read more

  • 10 October 2023

    dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for early life nutrition

    Read more

  • 4 October 2023

    dsm-firmenich provides additional pro forma financial information for 2022 and 2023

    Read more

  • 2 August 2023

    dsm-firmenich reports H1 2023 results

    Read more

  • 3 July 2023

    dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome

    Read more

  • 29 June 2023

    dsm-firmenich announces results of extraordinary general meeting of shareholders

    Read more

  • 28 June 2023

    Trading update and acceleration of strategic actions

    Read more

  • 22 May 2023

    Emmanuel Butstraen appointed as President of Perfumery & Beauty at dsm-firmenich

    Read more

  • 17 May 2023

    dsm-firmenich names Katharina Stenholm as Chief Sustainability Officer

    Read more

  • 9 May 2023

    dsm-firmenich launches as innovators in nutrition, health, and beauty

    Read more

  • 9 May 2023

    Completion of contribution of Firmenich shares

    Read more

  • 4 May 2023

    dsm-firmenich announces evolution of CEO structure per 1 September, following completion of the merger

    Read more

  • 2 May 2023

    DSM provides Q1 2023 trading update

    Read more

  • 1 May 2023

    Final results of the exchange offer: 96.1% of DSM ordinary shares tendered

    Read more

  • 18 April 2023

    dsm-firmenich first day of trading on Euronext Amsterdam

    Read more
See all
Explore more

  • dsm-firmenich at a glance

    Who we are. Why we merged. Where we’re going.

    Read more

  • Financial results

    All the key financial performance information published dsm-firmenich

    Read more

  • Share center

    All the key details on holding and trading shares of dsm-firmenich.

    Read more
Contact us